Name: Breast Cancer: From Bench to Personalized Medicine (en Inglés)
Price: 321840.00 CLP
Availability: InStock
Author: Shakil Malik, Saima ; Masood, Nosheen
ISBN: 9789811901966

portada Breast Cancer: From Bench to Personalized Medicine (en Inglés)

Formato

Libro Físico

Ilustrado por

Saima Shakil Malik

Nosheen Masood

Editorial

Springer

Autor

Shakil Malik, Saima ; Masood, Nosheen

Idioma

Inglés

N° páginas

536

Encuadernación

Tapa Dura

Dimensiones

23.4 x 15.6 x 3.0 cm

Peso

0.95 kg.

ISBN13

9789811901966

Categorías

Oncología
Genética (no médica)

Breast Cancer: From Bench to Personalized Medicine (en Inglés)

Saima Shakil Malik (Ilustrado por) · Nosheen Masood (Ilustrado por) · Springer · Tapa Dura

Libro Nuevo

$ 321.840

$ 643.680

Ahorras: $ 321.840

50% descuento

Envío normal

Origen: Estados Unidos (Costos de importación incluídos en el precio)

Se enviará desde nuestra bodega entre el Jueves 11 de Julio y el Jueves 18 de Julio.

Lo recibirás en cualquier lugar de Chile entre 1 y 3 días hábiles luego del envío.

Reseña del libro "Breast Cancer: From Bench to Personalized Medicine (en Inglés)"

This book provides detailed information on the etiology, pathogenesis, diagnosis, prognosis, and treatment strategies for breast cancer. The first section of the book presents epidemiology, risk factors, histopathological, immunohistochemistry, and molecular subtypes of breast cancer based on the receptor status. It also discusses the association of breast cancer with other hormone-sensitive cancers. The second section of the book covers cover BRCA1 and BRCA2-associated breast carcinogenesis, early-stage progression of breast cancer, and noninvasive biomarkers for the early detection of breast cancer. It also discusses the role of epigenetic modifications and non-coding RNAs in breast cancer metastasis and explores these as the biomarkers and therapeutic targets for breast cancer therapy.Further, it discusses the role of fibrinolytic mechanisms and circulating tumor cells in breast cancer diagnosis, prognosis, and treatment. The book also provides an update on oral poly(ADP-ribose) polymerase (PARP) inhibitors to treat breast cancer. Finally, it offers potential new options for personalized therapies for breast cancer patients, including optimizing drug dosage and identifying genetic changes associated with cancer symptom occurrence and severity.